Edgewell (EPC) reported robust financial performance in its second quarter fiscal year 2024 earnings call, with a 19% year-over-year increase in adjusted EBITDA and a surge of over 50% in adjusted earnings per share. The company experienced double-digit growth in international markets, yet faced a decline in North American sales due to transitory factors.
Edgewell has raised its full-year outlook for adjusted EBITDA and EPS, reflecting confidence in its strategies for the remainder of the fiscal year. Despite challenges in the U.S. market, the Grooming segment and international sales showed significant growth, while the company also returned $23.5 million to shareholders through repurchases and dividends.
Key Takeaways
- Adjusted EBITDA grew by 19% year-over-year, with adjusted earnings per share increasing by over 50%.
- International market sales saw double-digit growth, while North American sales declined.
- The Grooming segment's organic net sales rose by over 18%, driven by strong international performance and new product launches.
- Wet ones and Fem Care organic net sales declined due to retailer destocking and promotional intensity.
- Fiscal 2024 outlook includes 2% to 4% organic net sales growth and adjusted EBITDA between $348 million and $360 million.
- $23.5 million returned to shareholders through share repurchases and dividends.
Company Outlook
- Raised full-year outlook for adjusted EBITDA and EPS after a strong first half of the fiscal year.
- Plans to focus on productivity initiatives and invest in innovation and new product development.
- Anticipates organic net sales growth of 2% to 4% and adjusted gross margin accretion of 120 basis points.
Bearish Highlights
- Sales in North America declined due to cycling of last year's product launch and retailer inventory reductions.
- U.S. market faced a 4% decline in category performance and a 190 basis point decline in market share.
- Wet shave products impacted by weak sales in the drug channel and a slowdown in category growth.
Bullish Highlights
- Significant growth in the Grooming segment, with strong international performance.
- Adjusted gross margin rate, adjusted operating income, and adjusted earnings per share increased compared to the previous year.
- Accelerated growth internationally, with confidence in delivering higher profit margins.
Misses
- Wet ones organic net sales declined by 11%.
- Fem Care organic net sales were down 12%, primarily due to retailer destocking and promotional intensity.
Q&A Highlights
- Company focused on ROI and disciplined advertising and promotion (A&P) spending, with shifts towards retail execution and promotions.
- International markets growing faster, leading to less A&P spend there compared to North America.
- Fem Care business expected to be down in the first half but flat for the year.
- The launch of the Billie brand in women's grooming at Walmart (NYSE:WMT) showed positive momentum.
Edgewell's earnings call revealed a mixed but generally positive picture, with strong international growth and strategic shifts in spending to drive return on investment. The company's raised outlook for the fiscal year indicates a strong belief in its current trajectory, despite some challenges in the North American market. Edgewell's focus on productivity and innovation, along with its well-positioned portfolio to benefit from economic challenges, suggests a proactive approach to maintaining growth and profitability. Investors and market watchers will be looking forward to the company's update in August for further insights into its performance and strategic initiatives.
InvestingPro Insights
Edgewell's (EPC) latest financial results have painted a picture of a company that's navigating market challenges with a degree of success, especially in the international arena. To provide a more nuanced view of the company's financial health and future prospects, let's delve into some key metrics and InvestingPro Tips.
InvestingPro Data highlights a market capitalization of $1.94 billion, with a Price/Earnings (P/E) ratio of 15.52, which adjusts down to 13.88 when considering the last twelve months as of Q2 2024. This suggests a company that is potentially undervalued relative to its earnings. The company's revenue growth over the last twelve months stands at 1.98%, indicating steady, albeit modest, top-line growth. Furthermore, Edgewell boasts a solid gross profit margin of 42.33%, reflecting its ability to maintain profitability despite market fluctuations.
Two key InvestingPro Tips provide additional context to the company's financial narrative. First, Edgewell has a perfect Piotroski Score of 9, which is a strong indicator of financial stability and suggests that the company is well-positioned to weather economic headwinds. Second, management has been actively buying back shares, a sign of confidence in the company's valuation and future prospects. This is complemented by a high shareholder yield, which includes dividends and share repurchases, underscoring a commitment to returning value to investors.
For those interested in a deeper analysis, there are 6 additional InvestingPro Tips available, offering a comprehensive view of Edgewell's financial health and future outlook. To explore these insights and make informed investment decisions, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.
Full transcript - Edgewell Personal Care (NYSE:EPC) Q2 2024:
Operator: Good morning and welcome to Edgewell’s Second Quarter Fiscal Year 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Chris Gough, Vice President of Investor Relations. Please go ahead.
Chris Gough: Good morning, everyone, and thank you for joining us this morning for Edgewell’s second quarter fiscal year 2024 earnings call. With me this morning are Rod Little, our President and Chief Executive Officer; and Dan Sullivan, our Chief Financial Officer. Rod will kick off the call and then hand it over to Dan to discuss our results and full year fiscal 2024 outlook before we transition to Q&A. This call is being recorded and will be available for replay via our website, www.edgewell.com. During the call, we may make statements about our expectations for future plans and performance. This might include future sales, earnings, advertising and promotional spending, product launches, savings and costs related to restructuring and repositioning actions, acquisitions and integrations, changes to our working capital metrics, currency fluctuations, commodity costs, category value, future plans for return of capital to shareholders and more. Any such statements are forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995, which reflect our current views with respect to future events, plans or prospects. These statements are based on assumptions and are subject to various risks and uncertainties, including those described under the caption Risk Factors in our annual report on Form 10-K for the year ended September 30, 2023, as may be amended in our quarterly reports on Form 10-Q, which has been filed with the SEC. These risks may cause our actual results to be materially different from those expressed or implied by our forward-looking statements. We do not assume any obligation to update or revise any of these forward-looking statements to reflect new events or circumstances, except as required by law. During this call, we will refer to certain non-GAAP financial measures. These non-GAAP measures are not prepared in accordance with generally accepted accounting principles. A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures is shown in our press release issued earlier today, which is available at the Investor Relations section of our website. This non-GAAP information is provided as a supplement to not as a substitute for or superior to measures of financial performance prepared in accordance with GAAP. However, management believes these non-GAAP measures provide investors with valuable information on the underlying trends of our business. With that, I'd like to turn the call over to Rod.
Rod Little: Thank you, Chris. Good morning, everyone, and thanks for joining us on our fiscal ‘24 second quarter earnings call. We've delivered strong financial results in the quarter. Flight sales growth and accelerated gross margin gains of over 300 basis points drove 19% year-over-year adjusted EBITDA growth and over 50% adjusted earnings per share growth, both of which were above our expectations. Our strong margin results serve as the catalyst for the increase in our profit outlook for the full year, while reinforcing our commitment to return to pre-COVID level gross margins over time. I'm particularly pleased with the execution of our teams as margin expansion delivered in the quarter and embedded in our updated full year outlook is underpinned by a healthy balance of both accelerated realization of our productivity initiatives and disciplined execution of our strategic revenue management efforts. Combined these two initiatives drove over 400 basis points of gross benefit in the quarter. Organic net sales results in the quarter included a double-digit increase in our right to win portfolio, driven by our market leading Sun Care and Grooming businesses and continued growth across our international markets, reflective of both price and volume gains. I continue to be excited about the results we are seeing in our international markets. After posting 6% growth this quarter, these businesses have a two year stack growth rate of over 9%, driven by better execution, improved commercial capabilities, and importantly, stronger leadership. In Japan, our second largest standalone market, we had meaningful organic growth while gaining almost a market share Wet Shave. In Europe, our momentum continues with growth across both branded Wet Shave and our custom brands group. As we have begun to execute the relaunch of the Wilkinson Sword brand in market. And in Latin America, growth was driven by higher pricing and volumes reflective of a strong start to the Sun Care sees. In North America, as category consumption softened, sales and our right to play businesses of Wet Shave and Sun Care declined. Whether were certain transitory factors of play, including the cycling of last year's MPD pipeline fill at Costco (NASDAQ:COST) and Shave and retailer efforts to further reduce safety stock levels across Sun Care. The results in these categories for North America were below our expectations. Importantly, our results in North America across our right to win portfolio were very strong and in total we grew over 11% in the quarter, with gains in both with gains in both volume and price. Solid planogram outcomes, and good early season execution drove 13% growth in Sun Care and incremental distribution and new product rollouts in Cremo and the Billie launching the Body fueled over 20% organic sales growth in grooming. In summary, we operate a broad and diverse portfolio of global brands and our first half results are further proof that our strategy is working. For half one, we delivered 1.4% organic sales growth, 190 basis points of gross margin accretion invested over $111 million in support of our brands and increased operating cash flow by $54 million and realized over 26% adjusted earnings per share growth. As we turn to the second half of the year, our priorities are clear. We will continue to execute with excellence in support of our productivity program. We'll invest behind meaningful innovation and MPD across, Sun, grooming and body care, as well as our Carefree master brand launch. And finally, we will continue to deliver top and bottom-line growth across our international markets. With this, I'm confident in our organization's ability to be successful. And now, I'd like to ask Dan to take you through our second quarter results and discuss our outlook for fiscal ‘24. Dan?
Dan Sullivan: Thank you, Rod. Good morning, everyone. Despite what continues to be a challenging macro environment, strong operational and commercial execution has led to robust adjusted gross margin, EPS and EBITDA expansion in the quarter. Strong international results partially offset by the challenging performance of our right to play categories in North America led to slight organic sales growth, which was below our expectations. Continued excellent productivity performance and realization of our price and revenue management strategies, once again, unlock notable gross margin accretion, enabling us to raise our full year adjusted EPS and EBITDA outlook ranges, which I'll discuss shortly. For the quarter, organic net sales growth was largely driven by higher pricing and strategic revenue management actions, while volumes were lower. International organic growth was just under 6%, underpinned by both price and volume gains. As previously mentioned, the external environment is challenging. The dollar remains stubbornly strong while interest rates remain elevated. And importantly, consumption across U.S. categories has slowed. Aggregate consumption across our U.S. segments declined 0.4% in the quarter, a meaningful sequential step down from last quarter's 2%, 13 week growth and the 5% trailing 52 week trend, as gains from pricing eased compared to a year ago and volumes declined across most categories. The change in trend was most pronounced in Wet Shave and reflective of the drug channel, where we're seeing lower foot traffic, retailer execution challenges and a highly competitive environment on shelf. Operationally, our teams continued to execute at a high level. The supply chain organization realized better than expected productivity savings and our commercial teams drove strong gains from both price and revenue management. In total, these efforts combined to provide 430 basis points of gross margin tailwinds in the quarter, which more than offset core inflationary pressures and unfavorable mix. Notably, we delivered 320 basis points of adjusted gross margin accretion, adjusted EPS of $0.88 per share and adjusted EBITDA of $99.7 million, all of which were marked improvements over the previous year and above our expectations. Now, let me turn to the detailed for the quarter. Organic net sales increased 0.1% as strong performance across international markets and double-digit global growth in Sun Care and Grooming were offset by declines in North America Wet Shave and Fem Care. The strong international performance was driven by price gains of over 3% and volume gains of over 2%, resulting in just under 6% organic growth. Performance in Japan continued to be a highlight as a return to healthy category consumption was met with price execution and supported by incremental brand investment. Mid-single digit growth in Europe and high single digit growth across LATAM were noteworthy as well. Organic cells in North America were down 2.8%, as double-digit growth in Sun and Grooming was offset by declines in Wet Shave, Fem Care and Skin. North America volumes were down 5.4%, while pricing and revenue management delivered nearly 3 points of growth. Wet Shave organic net sales were down 4.5% with declines in men then women's systems and preps offset by slight growth in disposables. International Wet Shave grew mid-single-digits and from both price and volume gains, reflecting improved market conditions, solid distribution outcomes and strong in-market brand activation. In North America, organic net sales declined double-digits and were negatively impacted by cycling last year's MPD pipe fill in the club channel. Excluding the impact of the product launch cycling, total Wet Shave sales would've declined just under 2% in the quarter, which was in line with our expectations. In the U.S., razors and blades category consumption was down 3% in the quarter, driven mostly by the drug channel were declining traffic, weaker retailer performance and heightened promotional levels all dampened results. While our market share decreased 80 basis points overall, this was entirely driven by the aforementioned drug channel where we over index. Outside of drug, total category consumption was only marginally down and we gained market share including share expansion in mass. The Billie Brand continued to gain share, delivering 360 basis points of share growth as it continues to scale at retail. In the quarter, the brand reached a 16 share at Walmart and over 10 share at drug. Sun and Skin Care organic net sales increased approximately 12% as nearly 13% growth in Sun Care and 18% growth in Grooming were partially offset by declines in Skin. North America and international each grew Sun Care over 12% with both delivering volume and price gains. In the U.S., challenging early season weather was evident in category performance, which was down approximately 4% and our share declined 190 basis points. Grooming organic net sales increased over 18%, led by over 26% growth in Cremo in the U.S., over 12% growth in Bul Dog internationally and the rollout of Billie's Body Care launch at retail. Grooming organic growth excluding the Billie launch was a robust 11%. Wet ones organic net sales declined 11% and our shared decline slightly to approximately 73%. Fem Care organic net sales were down 12% for the quarter and the decline was more than expected. Consumption in the category was up 1.9%, though entirely driven by pads, as tampon consumption was flat and liners declined. The category continues to be impacted by retailer destocking and heightened promotional intensity, and we saw some executional delays in the changeover to the new planogram sets, which was a headwind in the quarter as we deploy our new Carefree master brands. Playtex Sport continues to be a drag with sluggish consumption and share performance. Now, moving down the P&L. Gross margin rate on an adjusted basis increased 320 basis points inclusive of 10 basis points of unfavorable currency. We delivered approximately 240 basis points of productivity savings and realized 190 basis points of price and strategic revenue management gains. This was partially offset by core gross inflationary pressures of about 60 basis points and 40 basis points of negative mix and other items. A&P expenses were 10.5% of net sales and flat to last year. Adjusted SG&A increased 20 basis points in rate of sale versus last year, as higher people related costs were only partly offset by savings realized from ongoing operational efficiency programs. Adjusted operating income was $80.7 million compared to $63.1 million last year, an increase of approximately 28%. Adjusted operating margin increased 300 basis points, reflecting higher gross margin, partially offset by higher A&P and SG&A expenses. GAAP diluted net earnings per share were $0.72 compared to $0.37 in the second quarter of fiscal ’23, and adjusted earnings per share were $0.88 compared to $0.56 in the prior year period. Currency movements had approximately $0.02 per share in unfavorable impact in the quarter, as translational currency benefits within operating profit were more than offset by transactional headwinds in operating profit and lower hedge gains within other income and expense. Adjusted EBITDA was $99.7 million inclusive of a $1.3 million unfavorable currency impact compared to $83.6 million in the prior year. Net cash provided by operating activities was $56.1 million for the first half compared to $1.9 million in the prior year period. We ended the quarter with $196 million in cash on hand access to the $309 million undrawn portion of our credit facility, and a net debt leverage ratio of 3.4x. In the quarter, share repurchases totaled $15 million and we continued our quarterly dividend payout and declared another cash dividend of $0.15 per share for the second quarter. In total, we returned $23.5 million to shareholders during the quarter. Now turning to our outlook for fiscal 2024. Our strong half one financial performance highlighted by accelerated year-over-year gross margin accretion provides the catalyst for our raising of the full year outlook for both adjusted EBITDA and EPS. We continue to expect organic net sales growth to be in the range of 2% to 4% so now anticipate the full year growth to be at the lower end of our previously provided range. This is largely reflective of 2Q results as our half two organic growth outlook remains mostly in line with our previous expectations and with a higher growth profile in Q4 than in Q3. We now expect full year adjusted gross margin accretion of 120 basis points, inclusive of 10 basis points of FX headwinds, and this represents a 40 basis point improvement over our previous outlook. Our outlook for margin expansion and half two is largely unchanged, as we expect stronger productivity gains and continued easing of inflation and FX to be offset by increased promotional levels and the negative impact of lower sales on capacity utilization. As mentioned, we're also increasing our outlook for adjusted EPS and EBITDA, essentially flowing through the over performance from 2Q to the full year, and holding half to generally consistent with our previous outlook. As modestly improved, FX is offset by the impact of slightly lower sales. Adjusted EBITDA is now expected to be in the range of $348 million to $360 million. Adjusted EPS is now anticipated to be in the range of $2.80 to $3 inclusive of approximately $0.17 per share of currency headwinds. Adjusted earnings per share at the midpoint of the range is now expected to increase approximately 12% or 18% at constant currency. For more information related to our fiscal ‘24 outlook, I would refer you to the press release that we issued earlier this morning. And now I'd like to turn the call back over to the operator for the Q&A session.
Operator: [Operator Instructions] The first question comes from Nik Modi with RBC (TSX:RY) Capital Markets.
Nik Modi: I got a just a few questions. Rod, I was hoping you can comment on the shelf resets being delayed because we're hearing this pretty broadly across a lot of companies across the space. I'm just curious if there's a specific dynamic that's kind of taking place that's causing that. And then the other question I had is just the drug channel seems like it doesn't look like it's going to recover anytime soon. It just seems like a lot of kind of missteps, executional issues, lack of focus on these categories. How do you think about the channel pivot, right? I mean, is this going to continue to be a drag in your business, as we kind of think out the next several quarters even maybe go even going into next fiscal year?
Rod Little: Both are things that we have been focused. On the first one on shelf resets being delayed, I think the broader thing that's happening where there are delays is lack of labor at the floor. That's one of the things we hear come back from the teams. I think that could be a macro factor. In our case though, the only thing that really has had any meaningful impact to us in the quarter was specifically in Fem Care and the timing change of the planogram reset, which we expected to be March, April became May. And the reason that impacted us more than others was around the fact that we are launching our Carefree master brand. With that planogram reset, effectively Sun setting the Stayfree brand, which we stopped shipping with the expectation that the planogram reset would happen in March, April. And when it got delayed to May, we were out of stock because we had run the stock down as we were converting everything into Carefree and now Carefree launches into May, across pads and liners. We're super excited about that master brand relaunch. It's coming with the technology innovation with a better top sheet. So we're excited actually about Fem for the second half of the year. The team's doing all the right things but it cost us over a point of growth in the quarter alone, with that timing delay, that was the biggest impact in fem along with the inventory reduction that others have talked about. And then as it comes to drug channel, what's interesting is you look at the U.S. market, you look at our share performance, how we performed against mass, against food, against e-com, on track with plans and across the board and specifically with shave. We are disproportionately impacted by problems in the drug channel because we're overdeveloped in that channel. We are seeing in our read throughs double-digit foot traffic declines in club, in addition to the things that are impacting CVS Walgreens every day. Within drug, you've got the labor issue, you've got the inflation issue, where the value equation there is maybe not quite as sharp as it is in some other retailers. So yes, I do think that's something that will be a drag for us. We'll face that as we cycle through that and those issues resolved themselves. But the other piece we had within the quarter and drug is Rite Aid (NYSE:US90274J5618=UBSS) went bankrupt and we're no longer shipping to a customer that was fairly meaningful in size to us. I expect that we'll get picked up other places, but that was also an impact in the quarter.
Operator: Our next question comes from Bill Chappell with Truist Securities.
Bill Chappell: I guess, first question, maybe in early indications on the, I mean, it seems like it's a fairly good start for Sun, especially internationally, but I know the season really doesn't start in earnest until we get to kind of really May, June. So maybe you can talk about how it's progressed as we moved into the fiscal third quarter and shelf space and kind of how you're set up versus especially versus last year.
Rod Little: Bill, the sun season, if you look at what we've done in the quarter, we grew 12% organic, primarily our shipments in right ahead of sun season in North America or in the Northern hemisphere, Southern hemisphere, a little different dynamic. But that 12% was equally represented internationally, up 12% -- North America, up 12%. So that's where we sit. We start the season domestically here in the U.S. with a slow start. If you look at early season weather patterns across the south, specifically down in the lower East Coast in Florida, start the year very rainy and worse than last year, if you want to direct compare in terms of where we started. Now that said, it is early. We're seeing that change now. If you look at the sun forecast and the temperature forecast across the south and southeast, that looks good. If you look at expected travel patterns, travel's going to be up again. It’s the projection that will be good. And our teams did an excellent job in the field getting distribution at or better than a year ago across the board. And one of the things that we're encouraged about is not only do we get the distribution but we've got some exciting new MPD on both Banana Boat and Hawaiian Tropic that led to some incrementality in shelf space. And Banana Boat 360 we've talked about in the past. It's a new non-aerosol delivery format for sprays to revolutionize the category that's been in sea sprays for 20 years in a different format that's very sustainable, recyclable bottles, reusable handle. I personally think it's the coolest innovation in the category this year, and so that also helps with the story. So now we laid 80% of the volume in front of us for the Sun to hit, we think it will hit. And we're also lapping, I believe, a fairly easy comp as you look at the weather patterns last year with fires, excessive heat and then a very rainy period through the northeast of the U.S. all the way through to July 4th weekend last year.
Bill Chappell: And then back to Grooming. I guess, I understand the weakness in the drug channel but I guess I'm trying to -- are there other things to fully explain why the category decline so much? Sequentially just you think about it as the drug channel is weak, the consumers would find it that other channels. And so, I'm just -- and what you've seen for that category as it -- as we've moved into the third quarter as well for the category more specifically the new.
Rod Little: And Bill, I just want to confirm Shave was the question. You said Grooming?
Bill Chappell: Sorry. Shave -- Wet Shave.
Rod Little: I know others use the Grooming term for the category, so I understand that. Look, we definitely have an impact happening in drug that impacts the full category. Offsetting that, you have fast growing e-commerce channel that's growing. I think at similar rates versus the past. However, we are seeing sequential slowing. If you go at a 52 week basis, our total aggregate, I think we said in the script was 5% growth. That was 2% in the prior quarter. It was about flat up 0.4% in this quarter. So we are seeing sequential slowing that is within Shave as well. Like Shave follows that same trend line effectively for us and there's a couple of things going on. There's an increased promotional intensity in the category, particularly in women's, it's very competitive as we roll Billie out national. You have a brand like Athena Club launching in and you've got the leading competitor being very promotional with their spend rates. We'll match that in the back half of the year and adjust our plans. But that's having a negative impact on the women's category. There's also, I think we're seeing a return to more normal historical elasticity conditions around price and volume, where if the price value equation is off a little bit, volume gets hit, and so some of that promotional intensity is adjusting value. I think we've seen a little bit of trade down to more value oriented price points with consumers. And then, I think we're seeing it in some of the data. It's early, but there's also an early indication that consumers are using product a little longer, right? As you look to how do you get the most out of what you have in your house if you're trying to manage your cash flow using a razor blade cartridge, an extra shave or two, giving logical consumer reaction when the consumer starts to get tight. And we're seeing a little bit of that in some traffic patterns. It's not something that's a driver of our results, but I think that's playing into one of the drivers of the category slowdown. And Dan, I don't know if you'd add anything.
Dan Sullivan: No, I think those are all the right points. I would add maybe two thoughts. I think one, the total Shave performance in the quarter bill was largely as we had profiled it, we actually weren't surprised so to say by the minus 4 or minus 4.5. Remember, we were cycling an NPD last year, and in and out in club, which we knew would be a headwind as we entered the quarter. I want to say one, we weren't surprised by the profile in the quarter. I think two, the only piece that I would add is there where we struggled in North America Shave and faced some headwinds and channels, as Rod articulated, we were equally accelerating internationally. And again, we don't talk a lot about it but the international represents over 50% of our Shave portfolio and we've now grown that double-digits for the first half of the year, up 6%, 5% in the quarter in 2Q. So I think putting it all in perspective, yes, some challenging environmental and price related items in the U.S. for sure. But heightened growth internationally as I mentioned. And then, yes, cycling an item from last year that profiled the quarter largely as we had expected it.
Operator: Next question comes from Chris Carey with Wells Fargo (NYSE:WFC) Securities.
Chris Carey: So what's your outlook for the North America business relative to international in the back half of the year? And if you could frame Wet Shave as well. And then secondly, can you talk about your ability to deliver on your higher profit outlook today, even if sales comes in below your current expectations? Does seem like there's a little bit of visibility dynamic that happened in Q2 that could continue into the back half. So I'm trying to understand how that might impact the profit model if indeed some of these things turn out to be a bit worse than you expected into the back half of the year.
Dan Sullivan: Yes, Chris, it’s Dan. I'll take them in reverse order. So we obviously have a very strong line of sight to the profit profile based on the margin performance that we've seen to date. And we're driving significant structural outperformance here on productivity and price and revenue management. So we certainly feel good about that. And as we said in the remarks, the Shave or the over performance through 2Q flows through. We're going to continue to push hard on that. I think you've seen that from us certainly on the productivity line. And we see now opportunities to over deliver for the full year. What we are anticipating in the back half of the year is a bit more promotional intensity. Rod mentioned that earlier in Shave, and also in Fem and we have factored in some capacity utilization headwinds in the back half of the year just due to the lower sales that we've seen. So we think we've been -- we've captured the right puts and takes. We do think pointing to the lower end of the range is the right place to be but we have high confidence in our ability to deliver now the improved margin performance. In terms of your first question on back half of the year, let me sort of put it in perspective. I'll start at the total company level. Because I think looking at what we are cycling is very important. For the first half of the year, we grew about 1.5% and we cycled 8% growth from a year ago. Our back half profile calls for about 2.5% growth, while recycling just over a point a year ago. So we start from a place that we think is constructive and thoughtful. Factoring in all the things you've heard us talk about, both within our portfolio and the broader markets. Specific to Shave, we're seeing now a category and therefore our performance within that category that largely levels back to the algorithm that we put in place a few years back when we launched the strategy, we're seeing now for organics, a flat to slightly declining organic that's largely what we've seen so far. For the first half of the year, we were up about 1 point, we're profiling half two to be down about 1 point. And that had put us for the full year plus or minus flat. Like that's kind of how we are thinking about it. We will see North America continue to let's say be at a lower growth rate than international. We then get an international continue to grow in the mid-single-digit range and outpace North America. So hopefully that answers your question.
Chris Carey: It does. One quick follow-up. The Sun Care business started the year really strong, but you're also talking about unfavorable weather and much of the season ahead. Can you talk about inventory levels in the Sun Care business? And what you would expect going into the back half of the year? And do we need the weather to start turning here in consumption to pick up to be working down these inventory levels? Any perspective there would be helpful.
Rod Little: Chris, so this is a domestic -- primarily a domestic U.S.
Chris Carey: This is really a domestic question.
Rod Little: But so from a seasonality perspective, the way the timeline lays out for the category is we begin to ship into retailers largely in our quarter two. So that 12% growth that we put up here in quarter two reflects growth over the prior year around effectively distribution and stocks that retailers are holding largely ahead of the season. The season will start in Jan-Fab down in Florida, and then work its way up and out. And so we sit today in a place with retailers feeling good about the season, committed to the season and effectively 12% more product out there than we had at this point year ago, despite what was a slow start to the season in the southeast and out on the west coast throughout the January, February, March period. What we'll now see though, is that inventory pull through that's there as we get into April, May and June, and replenishment orders begin as we get into our Q3. If we have a good sun season here at the start, which really gets into is Memorial Day good. And leading into that period, we'll see all that inventory move and replenishment go, which will drive Q3 and Q4 orders. And the dynamic we're seeing that's different in the past is Q4 is becoming a bigger proportion of the overall total on average because the season's gotten longer on average just around consumer behavior and habits of being outside more during that period. Those are the dynamics I think we feel really good about where we're set. I don't feel like anything is over inventoried but ultimately the sunshine and temperature will tell us if we're right or not on that.
Dan Sullivan: Chris, the only thing I would add, we always need good weather. We're sitting here today in our boardroom and you can barely see outside. It's dark and rainy and that's not good. But we're at a point now where what we are expecting, which we don't think is unrealistic is simply normalized replenishment cadence for the season. Now, we didn't get that last year because you remember May consumption was down 10%, June was down 5% and the season was changed forever from that point on. There's no reason to believe that will be the case this year for all the reasons Rod described, weather fires, smoke, you name it. We are -- our outlook contemplates simply normal replenishment of the season. And we're in a quarter now that's over 50% of the season. So yes, we do want to see some sunshine. And then to your question, we feel really good about inventory levels and I think more importantly, retailers remain extremely committed to the category. They understand that the press of the category starts now and there's a lot of opportunity here between now and 4 of July.
Operator: Our next question comes from Dara Mohsenian with Morgan Stanley (NYSE:MS).
Dara Mohsenian: I just wanted to touch on A&P spending levels. It's been in the 10% to 11% range as a percent of sales the last few quarters in the last couple years. You go back a few years pre-COVID, it was generally more in the 13% to 14% range. I know we've talked about previously, you guys are driving greater efficiency there, so that's why it's come down over time. But we are seeing your peers in the industry really ramp up A&P spend as a percent of sales looking to drive a volume recovery. We don't see it happening as much on your end despite some of the growth opportunities you're focused on and the gross margin recovery, your solid productivity. So just wanted to understand conceptually, A, why strategically we're not seeing more reinvestment in ad spend? B, do you think you're at the right levels in terms of share of voice relative to peers? And then -- and to support the volume recovery going forward. And then C, just what's the right level as a percent of sales maybe looking out longer term or are you pretty comfortable with where you are today?
Dan Sullivan: I'll start, and then I'll hand it to Rod. Look, I think we're going to continue to stay extremely disciplined here about where dollars drive ROI, that's the primary focus. We don't get too caught up in percent of sales metrics year-over-year. And so, we did expect to spend a bit more in the quarter, about a half a point more in revenue. And as we saw things getting delayed, Rod talked about that as we saw NPD being delayed, as we saw the sun season starting out a bit soft, we said, look, this isn't good spend and we're going to continue to follow that. We will step it up in the third quarter about a point of sales more than last year in support of the things that Rod talked around innovation and NPD and just good seasonal execution. But before I hand to Rod, I would make two comments though I think are important to understand just as you try to balance level of spend. I think one we did as we exited the quarter start to move dollars out of A&P into sort of shelf execution, retail execution, promotional dollars. We did do that. We expect we will continue to do that in the back half of the year. So I think, we've got to recognize that dollars are shifting now based on competitive move and category dynamics. It doesn't mean we're not spending, it means we're spending differently. And I think secondly, just purely rate of sale driven as international grows at an accelerated rate relative to North America it carries with it a lower A&P dollar. And so, you're going to actually get a mixed benefit here where the growth is coming from markets where we don't spend at the level we do in North America. So I think that's an important point. Rod, what would you add?
Rod Little: Yes, two things to add on top of that Dara. One, is as we return our gross margins back to that 45% plus range, which we're committed to doing, part of what we will do with that margin pickup over time is invest more in A&P. That's part of our model. That's part of our plan on how we think about delivering our growth algorithm for the future, which we're very confident we should do. It's going to come with some incremental support and spend on that A&P line over time. The thing that 0.2 that encourages me that we can do this in a way that's value creating is we have developed some internal data and analytics capability that is really, really impressive around where to spend next dollar. We're effectively doing in-house market mix modeling, big data and analytics to drive through to Dan's point on where is ROI and where do you spend the next dollar, which brand, which category, which customer, do you potentially go after much, much better analytics. And so as we create better branding, better messaging, we now have the analytics to point us where to spend with that. I think we're more willing to lean in and drive an increase in the rate because we know we'll get the return. I could not have said that to you two or three years ago. We've been on a journey there and yes, we want to spend more. We'll do it in a way that when we increase margin, we'll drop some to the bottom line and we'll reinvest in the business over time. That's what you should expect to see from us.
Operator: Our next question comes from Susan Anderson with Canaccord Genuity (TSX:CF).
Susan Anderson: I guess maybe just going back to the Fem Care business, I guess I'm curious how you're thinking about sales now for the year. It looks like down low-teens in the first half. I guess, should we think about getting most of that back to in flat for the year now or how should we think about that? And then I was curious too, just on the new launch, if you are getting any shelf gains.
Rod Little: You laid it out wrong Susan, that's exactly how you think about it. Down in the front half, up in the back half kind of flattish for the year plus or minus. We'll see where we landed. A lot of it's going to depend on off take here from the new initiative and what we put against it. But it's definitely a different profile in the second half. We don't think the inventory reduction piece that retailers are hitting us with. We've got the full planogram in place. And yes, we did gain shelf space as of effectively this month going forward with the new Carefree rollout. Dan, I don't know if you want to add anything.
Dan Sullivan: No, I think you said it well.
Susan Anderson: And then I was just curious, any early reads on the launch of Billie into women's grooming. I guess how many stores is that in now and what are you doing just to market that new launch and get consumers interested in the product?
Rod Little: It's exclusive at Walmart. As of this quarter, we just shipped in the new Billie Body execution. It's in a per sprint deodorant. It washes with moisturizer to follow. Not in yet. We are on track to ahead of initial assumptions that we had made around how big that could be. We feel good about it. Walmart, I believe if you asked them, we'll tell you they feel good about it. And we're excited about the momentum of the Billie brand, not only in grooming as we put the new body care skews in, but also what's happening on shave. We now have a shave business that's north of 10 share points and continuing to grow every single period. And so as we invest incrementally in awareness, which we are doing behind the body launch. We think we're going to be in a period where we can really start to get some halo and some efficiency in a multi-category exposure for the investment we make. Dan?
Dan Sullivan: Yes, all the right points. Susan, you're a big fan of the brand, so I'll add one comment. At Walmart in March, we executed a four-way mixed brand display. So the first time we've been able to do it in over 3000 doors and saw a 20% sequential growth. And so, to Rod's point, you've got a very strong Shave brand now that is essentially 17 share at Walmart with a growing presence in body and a really supportive retailer, who's willing to do incremental things on the floor, which is super helpful.
Operator: Our next question comes from Olivia Tong with Raymond James.
Olivia Tong: First, I want to follow up on Chris's question, because the savings and productivity that you've been able to achieve has been impressive as you improve that despite a weaker top line. But the things that you said, more promo in the second half, a couple of other things seem to suggest more drags on that. So I was wondering if you could talk about that. And then just on the top line, it seems like the tougher macros are hitting your categories harder than others. But you are in a weak -- in a unique position, excuse me, because of your private brands group. So was wondering if there's anything that you're doing there to help potentially offset some of the weakness with the branded portfolio.
Dan Sullivan: Hey, Olivia, it's Dan. I'll take the first question and then I'll hand to Rod for the second. Yes, look you are right. I mean we're, as I said earlier to Chris's question, we feel quite confident with the margin profile and the way that we've built it. We do think productivity and revenue management efforts will continue to outperform our initial expectation. We do feel that in the second half of the year, I think the team's done an amazing job both in execution of productivity and also in continued focus on unit economics and revenue management. What we are guarding against and trying to be thoughtful about is a couple of dynamics. One is reality, which is capacity utilization. You sell less, you produce less, you have less utilization on your manufacturing floor. And so, we've accounted for that in the back half of the year. And then as you mentioned, what we think will be a more promotional environment. Now, if I put all of that together, what it means is our margin outlook for the back half of the year is unchanged from our previous outlook. We have not changed anything. We think there's tailwinds in the stuff that we can really control around productivity and price. And we think that the environment will continue to be promotional and therefore we've contemplated that in the outlook. But for the half two, our margin outlook has not changed. So I'll hand it over to Rod.
Rod Little: Yes. And on the private brands group, we call it Edgewell Custom brands these our vernacular for it. We have a situation that as the consumer gets challenged, if economic conditions get more difficult on a macro basis, our portfolio sets up well to benefit from that. Not only is the value tier, for example, with Billie branded now in women's playing in disposables as well, but we also are the leader in that private label area and custom brands work, which is typically more to value price point. We are seeing better trends in that part of the business versus branded particular strength in Europe, in that business. I would call out, our execution in Europe has been outstanding in that part of the business and it is faster growing. We're not seeing big share shifts to private label, but we are definitely seeing strength in that part of our business, which we think is potentially a buffer for us. If the consumer does become more challenged from here, maybe it does put more macro hurt on our categories overall, but there's definite benefit in that part of the portfolio.
Operator: [Operator Instructions] Our next question comes from Peter Grom with UBS.
Peter Grom: I just wanted to follow-up on the margin question. You kind of just touched on productivity promotion already, but can you maybe just unpack what you really expect from the different buckets and kind of how that builds to the 40 basis point increase in the guide? You mentioned no change in the back half. I think FX is a little bit better. Is the remainder of the 40 basis point increase really just the function of stronger productivity in the first half? And then just building on that, can you maybe just comment on what you're seeing from a commodity perspective? You've started to see some costs tick higher here sequentially, so just would love to get some color on what you're seeing across your core cost basket.
Rod Little: Yes, we think for the year productivity efforts will deliver about 40 basis points upside to what we had originally forecast. We think price and revenue management will be right around 30 basis points higher than what we had initially forecast. There's a full year tailwinds. We think core inflation will continue to ease a bit helping as well. And then we anticipate mix and other items and that's where I get into the capacity utilization challenges, et cetera, and promotional items working as headwinds. And so if you put all of that together, you would get to about a 40 basis point increase in our full year margin versus what we had contemplated. The question on the commodity basket's a good one. And look, it's choppy, right, and I would say overall, nothing has changed here versus our thinking a quarter ago. You are right, there are always going to be movements within the basket. I think you see oil lately is moving to the low end. You see things like paper and pulp moving to the higher end. I think the team's doing an excellent job of balancing that, but we don't sit here today with any change in our risk profile to total commodity basket for the year.
Operator: This concludes our question-and-answer session. I would like to turn the conference back over to Rod Little for any closing remarks.
Rod Little: Thank you everybody. We appreciate your continued interest and investment, if you are an investor in the company. We'll work hard over the summer and we'll reconnect with you again in August for an update. Thank you.
Operator: The conference is now concluded. Thank you for attending today's presentation. You may now disconnect.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.